Want to join the conversation?
In 2016, $CR expects sales to approximate $2.7Bil, reflecting core sales in a range of -1.5% to 1.5%, and an approximate -2% impact from unfavorable FX. Diluted EPS is expected to be $3.85-4.15. Full year 2016 free cash flow is expected to be $190-220MM.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?